期刊文献+

金利胶囊对膝骨关节炎兔骨骼肌收缩蛋白基因与软骨基质蛋白多糖表达的影响 被引量:4

Influence of Liver-softening Formulation on Muscle Contractile Protein Gene and Cartilage Proteoglycans Expression in a Rabbit Model of Knee Osteoarthritis
下载PDF
导出
摘要 [目的]通过观察兔膝骨关节炎(KOA)骨骼肌蛋白与软骨基质蛋白多糖(PGs)表达,探讨柔肝中药金利胶囊治疗KOA的作用及机理。[方法]42只新西兰大白兔分为空白对照组(K组),模型对照组(MD组),金利干预组(R组);MD组与R组动物以改良Hulth法造模,R组造模并给药;取膝关节行番红/固绿染色、Mankin评分;RT-PCR检测肌肉α-肌动蛋白(-αactin)、重链肌球蛋白亚型(MHCⅠ,MHCⅡa,MHCⅡd/x,MHCⅡb)、Aggrecan与ADAMTS5 mRNA表达,检测关节软骨糖胺聚糖(GAG)水平。[结果]与模型组比较,R组Mankin评分降低,-αactin与多种MHC亚型mRNA表达水平上调(P<0.05);Aggre-can mRNA呈高表达,ADAMTS5 mRNA低表达(P<0.05)。[结论]金利胶囊能够延缓OA软骨退变,促进骨骼肌收缩蛋白基因表达,改善软骨基质蛋白多糖代谢。 [Objective]To investigate the mRNA expression of α-actin,MHC(myosin heavy chain),ADAMTS5 and Aggrecan in rabbit OA model.To Explore the mechanism of KingLi(liver-softening formulation) in the treatment of knee osteoarthritis.[Methods]42 healthy female adult New Zealand white rabbits were randomly divided into three groups(normal group,model group,KingLi group),establishing right knee OA model referring to Hulth's operation.One week after operation,interfering measures were taken into practice and lasted for 4 weeks.Cartilage sections were made and stained with Safranin'O/Fast Green for Mankin score.The mRNA expression level of α-actin,MHC isoforms in quadriceps femoris,Aggrecan and ADAMTS5 in cartilage was tested by RT-PCR.[Results]As to MHC isoforms,the level of MHCⅡa,MHCⅡd/x mRNA in model group was lower than that in normal control group(P0.05).KingLi was capable of up-regulating the mRNA level of α-actin and two MHC isoforms.The level of Aggrecan mRNA in model group was lower than that in normal control group(P0.05).The level of ADAMTS5 mRNA in model group was higher than that in normal control group(P0.05).KingLi was capable of up-regulating the level of Aggrecan mRNA expression(P0.05)and down-regulating the level of ADAMTS5 mRNA expression(P0.05).[Conclusion] KingLi was capable up-regulating the level of α-actin and MHC mRNA expression.KingLi was capable of delaying degeneration of cartilage in OA animals.KingLi was able to induce the expression of Aggrecan mRNA and inhibit the expression of ADAMTS5 mRNA.
出处 《浙江中医药大学学报》 CAS 2011年第3期378-380,386,共4页 Journal of Zhejiang Chinese Medical University
基金 国家重点学科 上海市重点学科(No:100508 T0303) 国家十一五支撑计划(No:2007BAI20B033) 国家自然基金资助项目(No:30371793 30300459 30500674) 国家中药管理局重点专病专科(No:09J1X1L116K110) 上海高校选拔培养优秀青年教师科研专项基金(No:szy08080)~~
  • 相关文献

参考文献7

  • 1Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis[J]. Nature, 2005,434 (7033) :644-8.
  • 2Stanton H, Rogerson FM, East CJ, et aI. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo andin vitro[J]. Nature, 2005,434 (7033) : 648-52.
  • 3Eid K, Thornhill TS, Glowacki J. Chondrocyte gene expression in osteoarthritis: Correlation with disease se- verity[J]. J Orthop Res, 2006,24(5) :1062-8.
  • 4Yagi R, McBurney D, Laverty D, et al. Intrajoint com- parisons of gene expression patterns in human osteoar- thrifts suggest a change in chondrocyte phenotype[J]. J Orthop Res, 2005,23(5) :1128-38.
  • 5Ikeda S, Tsumura H, Torisu T. Agerelated quadri- ceps-dominant muscle atrophy and incident radiographic knee osteoarthritis [J]. J Orthop Sci, 2005, 10 (2) : 121-6.
  • 6Short KR, Vittone JL, Bigelow ML, Changes in myo- sin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training [J]. J Appl Physiol, 2005,99(1) :95-102.
  • 7曹月龙,郑昱新,石印玉,史美育.养血软坚胶囊治疗膝骨关节炎疗效及安全性评价的随机对照试验[J].中国药物与临床,2004,4(6):423-427. 被引量:21

二级参考文献14

  • 1[1]Hochberg-Marc C, Altman-Roy D, Brandt-Kennenth D, et al.Guidelines for the medical management of osteoarthritis. Arthritis Rheum. 1995, 38: 1541-1546.
  • 2[4]Ahman R, Asch E, Bloch G, et al. Diagnostic and therapeutic criteria committee of the American rheumatism association: development of criteria for the classification and reporting of osteoarthritis:classification of osteoarthritis of the knee. Arthritis Rheum, 1986, 29: 1039-1049.
  • 3[5]Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA, 1949, 140: 659-662.
  • 4[6]Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol,1988, 15: 1833-1840.
  • 5[7]Cooperating Clinics Committee of the American Rheumatism Association. A seven day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum, 1965, 8: 302-334.
  • 6[8]Langley GB, Sheppeard H. Problems associated with pain measurement in arthritis: comparison of visual analogue and verbal rating scales. Clin Exp Rueumatol, 1984, 2: 231-232.
  • 7[9]Berman BM, Singh BB, Lao L, et al. A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee.Rheumatology, 1999, 38: 346-354.
  • 8[10]Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. (Part Ⅱ: osteoarthritis of the knee). Arthritis Rheum, 1995, 24:118-120.
  • 9[11]Deippe P. Towards effective therapy for osteoarthritis. Rheumatol Eur, 1995, 38: 1541-1546.
  • 10[12]Roth SH. NSAID gastropathy: a new understanding. Arch Intern Med, 1996, 156: 1623-1628.

共引文献20

同被引文献52

  • 1Schroeppel JP, Crist JD, Anderson HC, et al. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis[ J]. Histol Histopathol, 2011,26(3) :377 -394.
  • 2Dieppe P A,Lohmander L S. Pathogenesis and management of pain in osteoarthritis[J].The Lancet,2005,(9463):965.
  • 3Bellamy N,Buchanan W,et al. Validation study of WOM- AC:a health status instrument for measuring clinically im- portant patient relevant outcomers to antirheumatic drug therapy in patients with OSteoarthritis of the hip or knee[J]. J Rheumatol, 1988,15(12) : 1833.
  • 4Bliddal H, Christensen P, Riecke BF, et al. Osteoarthrltis - a role for weight management in rheumatology practice : an update [ J ]. Clin Obes,2011,1 ( 1 ) : 50 - 52.
  • 5Bellamy N, Buchanan WW, Goldsminth CH, et al. Valida- tion study of WOMAC:a health status instrument for meas- uring clinically important patient relevant outcomers to an- tirheumatic drug therapy in patients with osteoarthritis of the hip or knee [ J ]. J Rheumatol, 1988,15 (12) : 1833 - 1840.
  • 6Deshpande A, Bhargava D, Gupta M. Analgesic efficacy of acetaminophen for controlling postextraction dental pain[J]. Ann Maxillofac Surg,2015,4(2) :176 - 177.
  • 7Bannuru RR, Schmid CH, Kent DM, et al. Comparative ef- fectiveness of pharmacologic interventions for knee osteoar- thritls : a systematic review and network meta- analysis [ J ]. Ann Intern Med,2015,162( 1 ) :46- 54.
  • 8邱贵兴.骨关节炎诊治指南(2007年版)[J].中华关节外科杂志(电子版),2007,1(4):254-256. 被引量:404
  • 9张洪美,闵重函,张志强,李辉,荆琳,朝浩鹏,李延伟.膝骨关节炎关节液蛋白多糖的变化与中医辨证施治影响:随机分组对照[J].中国组织工程研究与临床康复,2008,12(20):3962-3965. 被引量:3
  • 10梁茂新,高天舒.《中药新药临床研究指导原则》脏腑诸证考察与分析[J].中国中医基础医学杂志,2008,14(5):330-331. 被引量:457

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部